Stock listing

Xenon Pharmaceuticals Inc.

Selected listing: A12ETN · LS · EUR · DE

Xenon Pharmaceuticals Inc. (Lang & Schwarz: A12ETN), Health Technology. Latest release Oct 2, 2026: Xenon Pharmaceuticals Reports Inducement Grants Under…

A12ETN:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A12ETN
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 2, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 1, 2026

Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

September 21, 2026

Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program

September 17, 2026

Xenon to Present at Wells Fargo Healthcare Conference

September 3, 2026

All Xenon Pharmaceuticals Inc. news →

Events

Replays

Xenon Pharmaceuticals Inc. (XENE) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
Xenon Pharmaceuticals Inc. (XENE) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call
Mon, Nov 03, 2025 · 04:30 PM ET
Watch

Research Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. company profile

View the public company page for Xenon Pharmaceuticals Inc. on 6ix.

Xenon Pharmaceuticals Inc. news

Read company news and market updates connected to Xenon Pharmaceuticals Inc..

Xenon Pharmaceuticals Inc. investor events

Find investor webinars, events, and replay context for Xenon Pharmaceuticals Inc..